After Earnings Scare, IBM's Dividend: Is It Still Safe?
IBM faced a tough earnings moment that rattled investors. This deep-dive breaks down dividend safety, what those numb...
Investing in your 20s can set the foundation for a secure retirement. Discover the best options to maximize your growth.
17,680 articlesIBM faced a tough earnings moment that rattled investors. This deep-dive breaks down dividend safety, what those numb...
Lucid Group has faced years of volatility, but Saudi backing and a clearer product roadmap could shift the odds. This...
A major hedge-like fund reduced its BlackLine stake, sending the stock lower. This article breaks down the why, what ...
A notable stake from an experienced manager in a healthcare diagnostics stock signals a thoughtful, long term thesis....
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Chewy just popped. stock momentum followed a better-than-expected 2026 outlook, even as Q4 growth stayed modest. This...
A fresh look at HAIN's Q3 2026 earnings and what it means for investors. Learn the metrics that matter, how to read t...
Elite investors are reorganizing their portfolios, and big names like bill ackman these super are making strategic be...
In a volatile energy market, two durable picks stand out as no-brainer energy stocks right for many portfolios. Learn...
If you manage rental property on your own, you might be leaving thousands on the table. This guide uncovers seven pla...
Prediction markets offer a different lens on big corporate moves. Discover what kalshi traders chance spacex says abo...
A major insider sale at TransMedics grabbed attention after the stock slumped about 45%. This article dives into what...